Results

Total Results: 6,952 records

Showing results for "weeks".

141. Treatment of Depression in Children and Adolescents: A Systematic Review - Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/Evidence%20Summary_0_0.pdf
     April 01, 2020 - We present end- of-treatment data for all studies; these vary widely from weeks to months. … TAU/UC 12-16 weeks Depressive symptoms, clinician- reported Mean difference (CDRS): 7.11; … active control 12 weeks Response Risk difference (CGI of 2 or less and at least a 50% reduction … Escitalopram also improves functional status and response and remission at 24 weeks. … pharmacotherapy 8-28 weeks (continued) Remission from MDD Risk difference (combination vs.

142. Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D2 Tables (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d2.xlsx
     January 01, 2024 - The planning CT or MRI was done 2 weeks before start of radiotherapy...Hormonal therapy was given to … (≥28 days) or 57 Gy in 19 fractions in 3·8 weeks (≥27 days)…All treatment groups received IMRT. … (≥28 days) or 57 Gy in 19 fractions in 3·8 weeks (≥27 days)…All treatment groups received IMRT. … (≥28 days) or 57 Gy in 19 fractions in 3·8 weeks (≥27 days)…All treatment groups received IMRT. … The two arms were each finished in about 5 weeks (5.5 weeks for MHF), facilitating the comparison of

143. Evidence Summary CER 208 Treatment For Bipolar Disorder In Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
     August 01, 2018 - placebo 5 RCT11, 16-19 (n=1199) 3 weeks Response Rate: Favors Olanzapine, OR 1.99 (95% CI 1.29, … placebo 4 RCT20-23 (n=1,007) 3 weeks Response Rate: Favors Quetiapine, OR 2.07 (95% CI 1.39, 3.09 … placebo 2 RCT25, 26 (n=584) 3 weeks Response Rate, YMRS, and CGI: Favors Risperidone (not pooled) … , 29, 30 (n=750) 3 weeks YMRS: No difference 3 RCTs18, 29, 30 (n=578) 3 weeks CGI: No difference … (n=453) 3 weeks Withdrawal (Overall, AE): No difference 1 IPD32 (n=453) 3 weeks Withdrawal (

144. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
     December 29, 2015 - , and 4 weeks, followed by 1 subcutaneous (SC) injection (75 mg or 150 mg) every 4 weeks;3 or secukinumab … 4 weeks, followed by one SC injection (75 or 150 mg) every 4 weeks. … , followed by 1 SC injection every 4 weeks. … ,42 or as 3 loading doses by IV infusion 10 mg/kg, at baseline, 2 weeks, and 4 weeks, followed by one … , and 4 weeks, followed by one SC injection (75 or 150 mg) every 4 weeks.

145. Evidence Summary Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
     October 01, 2021 - placebo controlled) of patients with chronic (mainly neuropathic) pain with short-term treatment (4 weeks … to 8.67) 6.46 (4 to 8.1)c 5.38 (4.67 to 6.14) 6.28 (6.12 to 6.44) Study Duration 4 to 15 weeks … 8 to 12 weeks 4 to 47 weeks 4 weeks 4 weeks Abbreviations: CBD = cannabidiol; CBDV = cannabidivarin … Key Question 2: Harms of cannabinoids for chronic pain compared with placebo in the short term (4 weeks … In the short term (4 weeks to <6 months), small magnitude improvements in pain severity and overall

146. Resident COVID-19 Vaccine Administration Record (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/nursing-home/materials/resident-covid-vaccine-administration-record.docx
     May 01, 2022 - Declined Location of Intramuscular Vaccination (place X in appropriate box) Pfizer ¨ *3 weeks … Left Arm ¨ Right Arm ¨ 2. ¨ 2. ¨ Left Arm ¨ Right Arm ¨ Moderna ¨ *4 weeks

147. Staff COVID-19 Vaccine Administration Record (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/nursing-home/materials/staff-covid-vaccine-administration-record.docx
     May 01, 2022 - Declined Location of Intramuscular Vaccination (place X in appropriate box) Pfizer ¨ *3 weeks … Left Arm ¨ Right Arm ¨ 2. ¨ 2. ¨ Left Arm ¨ Right Arm ¨ Moderna ¨ *4 weeks

148. EPC Methods: An Exploration of Methods and Context for the Production of Rapid Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-production_white-paper.pdf
     February 01, 2015 - Production Time: Less Than 4 Weeks Timeframe. … Production Time: 4 to 8 Weeks Timeframe. … used to make a decision at the end of those 2 weeks). … 12 weeks Yes N/A No N/A Yes No B1 Rapid review 3 days Yes N/A No No Yes No E2 Rapid review 4 weeks … One type relied on existing SRs. 1-2 weeks Two reports were conducted in 1 to 2 weeks.

149. Opportunity for Public Comment | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/opportunity-for-public-comment
     March 01, 2013 - Each draft Research Plan is posted for public comment for 4 weeks. … Review is shared with a panel of external subject matter experts and posted for public comment for 4 weeks … The USPSTF posts its draft Recommendation Statement on this Web site for public comment for 4 weeks. … The comment period for draft documents is 4 weeks.

150. The “Never Antibiotic” Diagnoses: Acute Bronchitis – Slides
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/bronchitis-slides.pptx
     September 01, 2022 - nonsmoker and has no past medical history presents with a cough that started after he had a cold 2 weeks … Acute Bronchitis The definition of acute bronchitis is the presence of a cough that lasts less than 3 weeks … Acute Bronchitis Patients with acute bronchitis should be told that their cough may last for at least 3 weeks … pain, if the cough increases in extent or frequency, or if a significant cough persists beyond three weeks

151. AHRQ's Safety Program for Nursing Homes: On-Time Pressure Ulcer Prevention | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/long-term-care/resource/ontime/pruprev/3.html
     December 01, 2017 - Report Description The Weight Summary Report displays 4 weeks of trended weight information for each … Often residents are on monthly weight schedules, so the Previous Weight may be 4 weeks prior to the Most … value of a resident with weight loss ≥2% from the previous week to the most recent week (where the 2 weeks

152. Screening for Gestational Diabetes Mellitus: Clinical Summary of U.S. Preventive Task Force Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6WFgDkD6kVsynLyYYMPVKk
     assess the balance between the benefits and harms of screening women for GDM either before or after 24 weeks … Screening Intervals Most screening is conducted between 24 and 28 weeks gestation. … balance of benefits and harms for screening for gestational diabetes mellitus, either before or after 24 weeks

153. CHIPRA 148: Section 5, Appendix 1 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-section-5-appendix-1.pdf
     October 12, 2013 - ADHD: Parent Management Training or other behavioral intervention x 8 weeks minimum, is first line for … disorders: Psychotherapy (e.g., Parent management training, parent child interaction therapy) x 10-20 weeks … ) x 8-12 sessions C (preschool) A (6-18yrs) Anxiety (GAD, SAD, SM, SP): CBT is first line, x 12 weeks … 18yrs) PTSD: Psychotherapy is first line (Child Parent Psychotherapy x 6 months minimum; or CBT x 12 weeks … Preschool; Play therapy) A (6-18yrs, CBT) OCD: CBT with parent involvement, behavioral therapy x 12 weeks

154. Text Description for PCPI eSpecification for BMI Assessment and Recommended Weight Gain (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/CHIPRA-BMI-Text-Descrip-PCPI-eSpec.pdf
     January 01, 2012 - The delivery is the trigger for the measure and the numerator quality actions will be limited to 44 weeks … 2.16.840.1.113883.3.526.03.1264 starts before start of [Procedure, Performed: Vaginal Delivery] <= 44 weeks … 2.16.840.1.113883.3.526.02.338 starts before start of [Procedure, Performed: Cesarean Section Delivery] <= 44 weeks … 2.16.840.1.113883.3.526.2.1448 Denominator Exceptions during FIRST [Encounter, Performed: Prenatal Visit] <= 44 weeks … Intervention Body Mass Index (BMI) Measurement during FIRST [Encounter, Performed: Prenatal Visit] <= 44 weeks

155. Appendix B. Clinical Materials to Share With Primary Care Providers | Agency for Healthcare Research and Quality
     www.ahrq.gov/es/patient-safety/settings/hospital/resource/nicu/packet/apb.html
     December 01, 2013 - Usually reach nadir of 7-10 g/dL at 4-8 weeks of life. … Iron administration before 10-14 weeks of age does not reduce the nadir, but iron is stored for later … pause that is accompanied by bradycardia (heart rate <100 bpm), cyanosis, or pallor in an infant <37 weeks … Can persist for many weeks in very preterm infants, although resolution typically occurs by 37-43 weeks … Monitoring should be limited to approximately 43 weeks' PMA or after the cessation of extreme episodes

156. Appendix B. Clinical Materials to Share With Primary Care Providers | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/hospital/resource/nicu/packet/apb.html
     December 01, 2013 - Usually reach nadir of 7-10 g/dL at 4-8 weeks of life. … Iron administration before 10-14 weeks of age does not reduce the nadir, but iron is stored for later … pause that is accompanied by bradycardia (heart rate <100 bpm), cyanosis, or pallor in an infant <37 weeks … Can persist for many weeks in very preterm infants, although resolution typically occurs by 37-43 weeks … Monitoring should be limited to approximately 43 weeks' PMA or after the cessation of extreme episodes

157. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
     December 16, 2011 - A) After 24 weeks’ gestation? B) During the first trimester and up to 24 weeks’ gestation? …  Population: Pregnant women (≥24 weeks’ gestation and <24 weeks’ gestation) without known preexisting …  Population: Pregnant women (≥24 weeks’ gestation and <24 weeks’ gestation) without known preexisting …  Population: Pregnant women (≥24 weeks’ gestation and <24 weeks’ gestation) without known preexisting … Population We will include studies that examine pregnant women ≥24 weeks’ or <24 weeks’ gestation

158. Secyfgzqgdoqdd8J4Ccvuy (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/SEcYfGZqGdoqdd8j4CCVuy
     May 01, 2008 - A) After 24 weeks’ gestation? B) During the first trimester and up to 24 weeks’ gestation? 2. … A) After 24 weeks’ gestation? B) During the first trimester and up to 24 weeks’ gestation? … A) After 24 weeks’ gestation? B) During the first trimester and up to 24 weeks’ gestation? … A) After 24 weeks’ gestation? B) During the first trimester and up to 24 weeks’ gestation? … After 24 weeks’ gestation?

159. Appendix-E-Cdspain-Sample-Clinical-Practice-Guidelines (doc file)
     digital.ahrq.gov/sites/default/files/docs/citation/appendix-e-cdspain-sample-clinical-practice-guidelines.docx
     October 16, 2020 - Slower taper speeds involve dose reduction by approximately 5-20% every 4 weeks, with pauses in taper … Standard taper speeds involve dose reduction by approximately 10% every 4 weeks. … Potential opioid withdrawal symptoms Early Symptoms (hours to days) Late Symptoms (days to weeks) … Prolonged Symptoms (weeks to months) · Anxiety/restlessness · Rapid, short respirations · Runny nose … ) Rapid Taper (over days) When 1 to 4 weeks after starting taper, then monthly before each reduction

160. Cer-250-Cannabis-2025-Surv-Rep-Update-Tables-E1-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
     January 01, 2025 - , crossover to ibuprofen 400 mg/day for 8 weeks 0.5 mg/day Ibuprofen 400 mg/day for 8 weeks, crossover … , cross over to ibuprofen 400 mg/day for 8 weeks Ibuprofen 400 mg/day for 8 weeks, crossover to nabilone … , cross over to ibuprofen 400 mg/day for 8 weeks Ibuprofen 400 mg/day for 8 weeks, crossover to nabilone … CBD 5 mg, increased during weeks 1-4 to a max daily dose of 10 capsules per day (50 mg). … , cross over to ibuprofen 400 mg/day for 8 weeks Ibuprofen 400 mg/day for 8 weeks, crossover to nabilone